// App-Quantinova.ai

1177-72 : A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF THE SAFETY AND EFFICACY OF PLASMID DNA EXPRESSING 2 ISOFORMS OF HEPATOCYTE GROWTH FACTOR IN PATIENTS WITH CRITICAL LIMB ISCHEMIA

Researchers

Presenter

  • Emerson C. Perin

Principal Investigators

  • Farrell Mendelsohn

  • Mark Davies

  • Donghoon Choi

  • Hau Pham

  • Jorge Saucedo

  • Alan Hirsch

  • William Marston

  • Wook-Bum Pyun

  • Seung-Kee Min

  • Brian G. Peterson

  • Anthony Comerota

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Critical limb ischemia

  • Deep vein thrombosis

  • Acute limb ischemia

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • Clusterin

  • Hepatocyte growth factor

  • Apoptotic body index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved